Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Therapeuticsmd Inc (TXMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,309,220
  • Shares Outstanding, K 216,400
  • Annual Sales, $ 19,360 K
  • Annual Income, $ -89,880 K
  • 36-Month Beta 1.22
  • Price/Sales 66.96
  • Price/Cash Flow 0.00
  • Price/Book 8.67

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.34 +38.02%
on 11/03/17
6.85 -12.55%
on 11/06/17
+0.99 (+19.80%)
since 10/24/17
3-Month
4.34 +38.02%
on 11/03/17
7.01 -14.55%
on 09/07/17
-0.13 (-2.12%)
since 08/24/17
52-Week
3.50 +71.14%
on 05/08/17
8.30 -27.83%
on 04/06/17
-1.16 (-16.22%)
since 11/23/16

Most Recent Stories

More News
Technical Snapshots for These Drug Makers Stocks -- AstraZeneca, Impax Laboratories, TherapeuticsMD, and GlaxoSmithKline

If you want a Stock Review on AZN, IPXL, TXMD, or GSK then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Drug Manufacturers companies develop and sell...

AZN : 33.84 (+0.03%)
IPXL : 17.05 (+0.59%)
TXMD : 5.99 (-0.99%)
GSK : 35.04 (-0.06%)
Short Interest Moves 35.8% Higher For TXMD

The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 14,724,459 share increase in total short interest for TherapeuticsMD Inc , to 55,856,043, an increase...

TXMD : 5.99 (-0.99%)
TherapeuticsMD to Present at Two Upcoming Investor Conferences

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the company will participate in the Stifel 2017 Healthcare Conference on November 14, and...

TXMD : 5.99 (-0.99%)
Clinical Studies Elevating Biotech Drug Development to New Levels for Unmet Medical Needs

PALM BEACH, Florida, November 7, 2017 /PRNewswire/ --

CARA : 12.39 (+1.64%)
CTXR : 4.80 (+3.90%)
ONCS : 2.12 (-3.64%)
TXMD : 5.99 (-0.99%)
VBLT : 6.95 (-0.71%)
Clinical Studies Elevating Biotech Drug Development to New Levels for Unmet Medical Needs

Commitment to bring new drug developments to the market through highly regarded and respected clinical research and studies are of a continued result of ongoing collaborations with academic and medical...

CARA : 12.39 (+1.64%)
CTXR : 4.80 (+3.90%)
ONCS : 2.12 (-3.64%)
VBLT : 6.95 (-0.71%)
TXMD : 5.99 (-0.99%)
Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and TherapeuticsMD

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / It was a good start to the week for Teva Pharmaceutical on Monday, as a Reuters report revealed that a British billionaire may be interested in a $3 billion...

TEVA : 13.70 (+1.63%)
TXMD : 5.99 (-0.99%)
TherapeuticsMD Announces Third Quarter 2017 Financial Results

--- Submission of New Drug Application for TX-001HR expected in December 2017 -

TXMD : 5.99 (-0.99%)
TherapeuticsMD, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 6, 2017 / TherapeuticsMD, Inc. (NASDAQ: TXMD) will be discussing their earnings results in their Q3 Earnings Call to be held on November 6, 2017 at 8:00 AM Eastern...

TXMD : 5.99 (-0.99%)
TherapeuticsMD Announces Plan to Resubmit the New Drug Application for TX-004HR

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced a regulatory update regarding the New Drug Application (NDA) for TX-004HR, the Company's investigational...

TXMD : 5.99 (-0.99%)
TherapeuticsMD to Host TX-004HR Regulatory Update and Third Quarter Financial Results Conference Call and Webcast on November 6

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that it will host a conference call and live audio webcast to discuss a TX-004HR regulatory...

TXMD : 5.99 (-0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

See More

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

2nd Resistance Point 6.16
1st Resistance Point 6.07
Last Price 5.99
1st Support Level 5.91
2nd Support Level 5.84

See More

52-Week High 8.30
Fibonacci 61.8% 6.47
Last Price 5.99
Fibonacci 50% 5.90
Fibonacci 38.2% 5.33
52-Week Low 3.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart